Zhongnan Medical Journal Press

Home Results

A total of 15 result was found. Results that relate to Benign prostatic hyperplasia

Clinical pathway interpretation of transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia

Published on New Medicine 2022,32(1):214-222.
12424 times 3305 times

Si-Yu YAN Xing HUANG Zheng CHEN Lu YANG Zhao-Hui JIA Mou PENG Xuan-Yi REN Jing XIONG Xiao-Dong LI Xiao-Feng XU Zhong-Yi SUN Yong-Bo WANG Xu-Hui LI Wan-Li HU Ting WANG Ying-Hui JIN Hao ZI Tong-Zu LIU Xian-Tao ZENG Da-Lin HE Xing-Huan WANG Urological Association of Chinese Research Hospital Association Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care Project Group for Minimally Invasive Plasmakinetic Surgery System Development and Industrialization of the National Key Research and De-velopment Program

Clinical pathway Benign prostatic hyperplasia Lower urinary tract symptoms Tran-surethral plasmakinetic resection Plasma bipolar resection Evidence-based medicine
Details
Complications of transurethral plasmakinetic resection of prostate: a systematic review and meta-analysis

Published on New Medicine 2021,31(1):88-99.
12245 times 4535 times

Bing-Hui LI Shi-Di TANG Yong-Bo WANG Si-Yu YAN Jia-Ao LOU Yu-Qing DENG Tong DENG Ying-Hui JIN Xiao-Dong LI Xian-Tao ZENG

Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia Complications Incidence Systematic review Meta-analysis
Details
Effects of tamsulosin and alfuzosin on quality of life and sexual function in patients with benign prostatic hyperplasia

Published on Frontiers in Pharmaceutical Sciences 2023,36(10):111-118.
9239 times 2469 times

Sai-Feng HU An Ding HU Ting-Zhao QIAN

Benign prostatic hyperplasia Tamsulosin Alfuzosin
Details
The research progress on multi-omics analysis biomarkers of benign prostatic hyperplasia

Published on New Medicine 2024,34(2):206-216.
10466 times 3859 times

QIAN Xinhang GU Jiamin LU Peiwen YANG Shisong FANG Cheng LI Xiaodong ZENG Xiantao

Benign prostatic hyperplasia Biomarkers Multi-omics analysis Aging
Details
Benign prostatic hyperplasia and periodontitis

Published on New Medicine 2024,34(3):330-338.
6905 times 2106 times

YANG Shisong ZHU Cong QIAN Xinhang HOU Junqing FANG Cheng

Benign prostatic hyperplasia Periodontitis Inflammation Oxidative stress
Details
Transurethral plasmakinetic resection of prostate in high-risk benign prostatic hyperplasia patients: a multicenter prospective study

Published on New Medicine 2024,34(4):381-390.
10190 times 2830 times

LI Fei GENG Jie CHEN Hongbo ZHOU Zhijun LIU Xiaohua SHI Hongbo DU Dan ZHU Tao ZHANG Jingyu LI Xiaodong QUE Hui SONG Hongfei YAO Qisheng DOU Zhongling RUAN Jianzhong ZHENG Jiang ZHU Ziqing REN Xuanyi HUANG Qiao GONG Kan LIU Tongzu HE Dalin ZENG Xiantao

Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia High-risk patients Cardiovascular diseases
Details
Consistency of ultrasonography and magnetic resonance imaging in measuring prostate size and volume

Published on New Medicine 2024,34(5):530-537.
10330 times 2430 times

MAO Xiaoli ZI Hao ZHANG Jie LIU Shuangtai HUANG Qiao LI Binghui ZENG Xiantao

Benign prostatic hyperplasia Prostate Size Volume Ultrasonography Magnetic resonance imaging Consistency
Details
Analysis of the disease burden of benign prostatic hyperplasia in China, the United States and Germany at 1990 and 2019

Published on New Medicine 2024,34(5):545-553.
10802 times 2428 times

LU Peiwen ZI Hao QIAN Xinhang MING Daojing FANG Cheng LI Xiaodong

Benign prostatic hyperplasia Disease burden Prevalence rate Incidence rate Years lived with disability
Details
Relationship and potential mechanisms between gut microbiota and benign prostatic hyperplasia

Published on New Medicine 2024,34(5):582-592.
10144 times 2171 times

WANG Congcong ZHANG Jie GUO Mengmeng LI Luyao ZENG Xiantao ZHANG Yuanyuan WANG Shuangying QIN Changjiang

Gut microbiota Benign prostatic hyperplasia Sex hormones Inflammation Metabolic disorders
Details
Research progress on the role of PI3K/AKT signaling pathway in benign prostatic hyperplasia and traditional Chinese medicine intervention

Published on Journal of Mathematical Medicine 2024,37(10):775-785.
11742 times 2243 times

ZHAO Yuanbo [Z GAN Decheng LU Ganggang LI Shenglong

Benign prostatic hyperplasia PI3K/AKT signaling pathway Prostate cells Traditional Chinese Medicine
Details
The analysis of disease burden of benign prostatic hyperplasia in China from 1990 to 2021

Published on New Medicine 2024,34(12):1329-1336.
11280 times 2058 times

HU Yan WANG Xin CHEN Xianyan ZI Hao ZHU Cong FANG Cheng ZHAO Yongwei ZENG Xiantao

Benign prostatic hyperplasia Disease burden Incidence Prevalence Disability-adjusted life years
Details
Associations among immunophenotype, plasma metabolites, and benign prostatic hyperplasia: a mediation Mendelian randomization study

Published on New Medicine 2025,35(1):73-82.
7104 times 1293 times

FAN Jiuming ZHAO Yiqiao JIA Haichang WANG Tiankun HAN Yutong QI Zihao CHEN Ping ZENG Xiantao

Benign prostatic hyperplasia Mendelian randomization Immunophenotypes Plasma metabolites Exposure-mediator-outcome pathway Mediation analysis
Details
The association between periodontitis, plasma inflammatory factors, and benign prostatic hyperplasia: a mediation Mendelian randomization study

Published on New Medicine 2025,35(3):312-318.
6013 times 1299 times

JIA Haichang FAN Jiuming FANG Cheng ZENG Xiantao

Periodontitis Benign prostatic hyperplasia Inflammatory factors Mendelian randomization Mediation analysis
Details
The role of zinc homeostasis in prostate diseases and potential mechanisms

Published on New Medicine 2025,35(7):846-854.
7930 times 986 times

HAN Yutong FAN Jiuming WANG Tiankun QI Zihao ZHANG Yuanyuan HOU Junqing

Zinc Zinc Homeostasis Prostatic diseases Prostate cancer Benign prostatic hyperplasia
Details
Integrated network pharmacology and molecular docking to explore the potential molecular mechanisms of diosmin against prostatic hyperplasia complicated with chronic prostatitis

Published on Frontiers in Pharmaceutical Sciences 2025,29(12):1981-1989.
1459 times 307 times

TANG Liu JIANG Xiao LUO Guangwen WANG Lei

Diosmin Benign prostatic hyperplasia Chronic prostatitis Network pharmacology Molecular docking Signaling pathway GO funnction analysis KEGG pathway analysis
Details